sacituzumab,Pembrolizumab,Avelumab,Zimberelimab,Domvanalimab
Gilead,Merck,Pfizer,Arcus Biosciences,Otsuka
['muc ,(-much)', 'trophy,u-01', 'sacituzumab', 'cohort 1', 'sacitu, govi']
safety analysis by ugt1a1 status of #trophy-u-01 cohort 1, a phase 2 study of sacituzumab govitecan in pts with #muc who progressed after platinum-based chemotherapy &amp; a checkpoint inhibitor - . #asco23 coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology